000147522 001__ 147522
000147522 005__ 20240229133153.0
000147522 0247_ $$2doi$$a10.1007/s00125-019-05017-2
000147522 0247_ $$2pmid$$apmid:31705160
000147522 0247_ $$2ISSN$$a0012-186X
000147522 0247_ $$2ISSN$$a1432-0428
000147522 0247_ $$2altmetric$$aaltmetric:70045691
000147522 037__ $$aDKFZ-2019-02576
000147522 041__ $$aeng
000147522 082__ $$a610
000147522 1001_ $$aNiersmann, Corinna$$b0
000147522 245__ $$aHigher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes.
000147522 260__ $$aHeidelberg$$bSpringer$$c2020
000147522 3367_ $$2DRIVER$$aarticle
000147522 3367_ $$2DataCite$$aOutput Types/Journal article
000147522 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636705141_5414
000147522 3367_ $$2BibTeX$$aARTICLE
000147522 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147522 3367_ $$00$$2EndNote$$aJournal Article
000147522 500__ $$aDiabetologia. 2020 Feb;63(2):410-418#LA:C070#
000147522 520__ $$aHigher concentrations of the adipokine omentin are associated with lower levels of cardiometabolic risk factors in experimental and cross-sectional studies, but with higher risk of type 2 diabetes and cardiovascular diseases in population-based cohort studies. However, it is unknown whether high omentin concentrations are associated with increased risk of cardiovascular events in people with established diabetes. Therefore, the present study investigated the association between serum omentin concentrations and the risk of cardiovascular events in individuals with diabetes.This prospective study was based on participants of the German ESTHER cohort with diabetes and without previous cardiovascular event. The ESTHER cohort consists of individuals aged 50-75 years at baseline who were recruited by their general practitioners. After exclusion of individuals with serum C-reactive protein ≥10 mg/l (≥95.24 nmol/l), the final analysis population consisted of 933 individuals. At baseline, serum omentin concentrations were measured by ELISA. Cox regression models were fitted to estimate HRs and their corresponding 95% CIs for associations of omentin tertiles with a composite endpoint of cardiovascular events and separately with incident myocardial infarction, stroke and cardiovascular death.During 14 years of follow-up, 228 individuals experienced a primary cardiovascular event (myocardial infarction, stroke or cardiovascular death). After comprehensive adjustment for age, sex, BMI, metabolic and lifestyle factors and medication use, HRs (95% CIs) for the 2nd and 3rd tertile of omentin compared with the 1st tertile were: 1.24 (95% CI 0.86, 1.79) and 1.63 (1.15, 2.32) (ptrend = 0.005) for the composite cardiovascular endpoint; 1.39 (0.78, 2.47) and 1.71 (0.98, 2.99) (ptrend = 0.065) for incident myocardial infarction; 1.40 (0.78, 2.53) and 2.05 (1.17, 3.58) (ptrend = 0.010) for incident stroke; and 1.43 (0.85, 2.40) and 1.72 (1.04, 2.83) (ptrend = 0.040) for cardiovascular death. Effect estimates and p values were almost unaltered after additional adjustment for adiponectin.Higher omentin concentrations are associated with an increased risk for cardiovascular events in individuals with diabetes after adjustment for multiple cardiovascular risk factors. Given data from preclinical studies, it appears possible that this association reflects a compensatory, but insufficient upregulation of omentin concentrations as a response to stimuli that increase cardiovascular risk.
000147522 536__ $$0G:(DE-HGF)POF3-323$$a323 - Metabolic Dysfunction as Risk Factor (POF3-323)$$cPOF3-323$$fPOF III$$x0
000147522 588__ $$aDataset connected to CrossRef, PubMed,
000147522 7001_ $$aCarstensen-Kirberg, Maren$$b1
000147522 7001_ $$aMaalmi, Haifa$$b2
000147522 7001_ $$aHolleczek, Bernd$$b3
000147522 7001_ $$aRoden, Michael$$b4
000147522 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$udkfz
000147522 7001_ $$00000-0002-2050-093X$$aHerder, Christian$$b6
000147522 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b7$$eLast author$$udkfz
000147522 773__ $$0PERI:(DE-600)1458993-x$$a10.1007/s00125-019-05017-2$$n2$$p410-418$$tDiabetologia$$v63$$x1432-0428$$y2020
000147522 909CO $$ooai:inrepo02.dkfz.de:147522$$pVDB
000147522 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000147522 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000147522 9131_ $$0G:(DE-HGF)POF3-323$$1G:(DE-HGF)POF3-320$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lHerz-Kreislauf-Stoffwechselerkrankungen$$vMetabolic Dysfunction as Risk Factor$$x0
000147522 9141_ $$y2020
000147522 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000147522 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147522 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147522 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000147522 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bDIABETOLOGIA : 2017
000147522 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147522 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000147522 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147522 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147522 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000147522 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000147522 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000147522 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bDIABETOLOGIA : 2017
000147522 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000147522 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000147522 980__ $$ajournal
000147522 980__ $$aVDB
000147522 980__ $$aI:(DE-He78)C070-20160331
000147522 980__ $$aUNRESTRICTED